BIMOVIS GmbHBIMOVISUnlock the Power of Structural BiologyIn this interview Dr. Martin Stieler, founder and CEO of BIMOVIS, introduces his company and the importance of structural biology in biotech and pharmaceutical industries, and highlights how BIMOVIS … more ➔
Indivumed GmbHDrug DiscoveryEvolving Antibody Innovation: New frontiers in cancer R&DFifty years after the invention of hybridoma technology, biologics have become a cornerstone of oncology drug discovery and development. From the first monoclonal antibody approval in 1995 to today’s … more ➔
T3 PharmaceuticalsBasel AreaHow T3 scaled faster in Basel’s biotech labsT3 Pharmaceuticals shows how a biotech can move from first experiments to a major international deal keeping pace – and roots – in the Basel Area. The team built, tested and scaled inside Switzerland … more ➔
Celonic GroupAllianceCelonic’s Strategic Alliance in ADCsThe Celonic Group and CARBOGEN AMCIS AG have formed a strategic alliance to offer a fully integrated Antibody Drug Conjugate (ADC) development and manufacturing platform. This partnership combines Celonic’s … more ➔
Wien-Tourismus/Christian-StemperBiotech clustersVienna: The centre of the European biotech worldThis year, BIO-Europe, Europe’s leading partnering event for the entire biotech ecosystem, will take place in Vienna. From 3 to 5 November, the industry’s most important decision-makers will meet here … more ➔
Rezon BioRezon BioMeeting global market challengesThe global biologics industry is entering a new phase of maturity. As costs tighten and timelines accelerate, CDMOs must deliver uncompromised quality while driving efficiency. Rezon Bio, an EU-based … more ➔
Gene TherapyInnovative Approaches to Gene TherapyWatch this expert-led session to explore the latest trends and insights in gene therapy, including how to model immunosuppressive regimens, key study-design considerations, and the importance of age … more ➔
Whitepaper Digital ManufacturingTackling 5 Key Challenges in Annex 11 and MHRA ReadinessDownload the guide to explore how forward-thinking organisations are leveraging digital transformation in manufacturing to overcome regulatory challenges, enhance compliance, and gain operational efficiencies … more ➔
New England BiolabsThe Bridge to your successCustomized Enzymes and Reagents from New England Biolabs. Creating the right partnership is essential when pioneering a new life science product. more ➔
Biomedical Research and TherapeuticsProPure™: Raising the Bar in Life Science ResearchIn biomedical research and biomanufacturing, the purity of reagents directly impacts the reliability of experimental outcomes and the safety of downstream therapeutic products. Endotoxins are notorious … more ➔
BIMOVIS GmbH![Approvals of antibody-based therapies have accelerated sharply since 2000 with oncology dominating the landscape, newer modalities like ADCs and bispecifics gaining momentum [2]](https://european-biotechnology.com/wp-content/uploads/2025/10/Seite-71_EB325_Indivumed_Grafik1_RZ_X3-300x169.png)
Indivumed GmbH
T3 Pharmaceuticals
Celonic Group
Wien-Tourismus/Christian-Stemper
Rezon Bio
